Merck & Co. (MRK)

Cash & Short-Term Investments

$7.14B

Quarterly · Period ending: · USD

MRK logo

MRK Cash & Short-Term Investments

Latest reported$7.14B
MRK Quarterly Cash & Short-Term Investments ($842.00M → $7.14B)
High-resolution chart · PNG

MRK cash & short-term investments history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Merck & Co. Cash & Short-Term Investments — Quarterly (USD)
Period endingCash & Short-Term Investments (USD)
7,141,000,000
5,702,000,000
14,565,000,000
18,214,000,000
8,622,000,000
9,228,000,000
13,689,000,000
14,593,000,000
11,354,000,000
5,619,000,000
7,093,000,000
8,773,000,000
6,378,000,000
10,387,000,000
13,192,000,000
11,248,000,000
10,128,000,000
8,928,000,000
8,096,000,000
10,016,000,000
8,575,000,000
6,981,000,000
8,050,000,000
7,356,000,000
11,103,000,000
7,432,000,000
10,450,000,000
8,018,000,000
7,105,000,000
8,798,000,000
8,864,000,000
10,285,000,000
7,594,000,000
7,346,000,000
8,498,000,000
11,195,000,000
11,967,000,000
15,249,000,000
14,341,000,000
13,067,000,000
11,834,000,000
12,943,000,000
13,427,000,000
12,089,000,000
11,370,000,000
15,601,000,000
15,719,000,000
14,347,000,000
13,395,000,000
20,513,000,000
17,486,000,000
18,169,000,000
18,098,000,000
16,022,000,000
16,141,000,000
18,117,000,000
17,450,000,000
15,566,000,000
14,972,000,000
15,576,000,000
13,981,000,000
13,029,000,000
12,201,000,000
10,624,000,000
9,942,600,000
9,777,300,000
9,604,000,000
22,256,300,000
16,932,300,000
12,581,600,000
5,486,400,000
6,841,300,000
9,987,500,000
9,163,700,000
8,230,800,000
7,391,500,000
5,504,000,000
4,056,200,000
8,713,000,000
9,087,000,000
10,464,400,000
12,401,500,000
15,637,600,000
14,028,000,000
13,030,700,000
9,438,400,000
7,089,900,000
6,956,800,000
6,177,100,000
5,311,900,000
4,173,000,000
6,292,700,000
5,715,500,000
5,137,300,000
4,971,200,000
3,985,100,000
3,109,500,000
4,506,100,000
3,286,600,000
3,849,400,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.